AIM ImmunoTech Inc.

09/12/2024 | Press release | Distributed by Public on 09/12/2024 14:46

Management Change/Compensation Form 8 K

Item 3.02. Unregistered Sales of Equity Securities

The disclosure regarding the shares of common stock set forth under Item 5.02 is incorporated by reference into this Item 3.02.